Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus
Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus have?
Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus has 17 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus published?
Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus has 2018 year in the ScholarIQ index.
What is the open-access status of Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus?
Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus has closed oa status in the ScholarIQ index.
What is the DOI of Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus?
The DOI for Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus is on the source record.
What is the PMID of Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus?
The PMID for Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus is on the source record.
What is the OpenAlex record for Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus?
The OpenAlex for Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus is on the source record.